Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy

Nicholas J. Short; Elias Jabbour; Lewis F. Nasr; Nitin Jain; Fadi G. Haddad; Ghayas C. Issa; Koji Sasaki; Jayastu Senapati; Partow Kebriaei; Rebecca Garris; Marina Konopleva; Farhad Ravandi; Hagop Kantarjian

doi:10.1002/ajh.27329

Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy

Nicholas J. Short, Elias Jabbour, Lewis F. Nasr, Nitin Jain, Fadi G. Haddad, Ghayas C. Issa, Koji Sasaki, Jayastu Senapati, Partow Kebriaei, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1423-1426
Number of pages	4
Journal	American journal of hematology
Volume	99
Issue number	7
DOIs	https://doi.org/10.1002/ajh.27329
State	Published - Jul 2024

ASJC Scopus subject areas

Hematology

Access to Document

10.1002/ajh.27329

Cite this

Short, N. J., Jabbour, E., Nasr, L. F., Jain, N., Haddad, F. G., Issa, G. C., Sasaki, K., Senapati, J., Kebriaei, P., Garris, R., Konopleva, M., Ravandi, F., & Kantarjian, H. (2024). Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. American journal of hematology, 99(7), 1423-1426. https://doi.org/10.1002/ajh.27329

Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy. / Short, Nicholas J.; Jabbour, Elias; Nasr, Lewis F. et al.
In: American journal of hematology, Vol. 99, No. 7, 07.2024, p. 1423-1426.

Research output: Contribution to journal › Letter › peer-review

Short, NJ , Jabbour, E, Nasr, LF, Jain, N , Haddad, FG , Issa, GC , Sasaki, K , Senapati, J , Kebriaei, P, Garris, R, Konopleva, M, Ravandi, F & Kantarjian, H 2024, 'Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy', American journal of hematology, vol. 99, no. 7, pp. 1423-1426. https://doi.org/10.1002/ajh.27329

@article{af31dec493264927b330cf3da53ba52e,

title = "Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy",

author = "Short, {Nicholas J.} and Elias Jabbour and Nasr, {Lewis F.} and Nitin Jain and Haddad, {Fadi G.} and Issa, {Ghayas C.} and Koji Sasaki and Jayastu Senapati and Partow Kebriaei and Rebecca Garris and Marina Konopleva and Farhad Ravandi and Hagop Kantarjian",

year = "2024",

month = jul,

doi = "10.1002/ajh.27329",

language = "English (US)",

volume = "99",

pages = "1423--1426",

journal = "American journal of hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy

AU - Short, Nicholas J.

AU - Jabbour, Elias

AU - Nasr, Lewis F.

AU - Jain, Nitin

AU - Haddad, Fadi G.

AU - Issa, Ghayas C.

AU - Sasaki, Koji

AU - Senapati, Jayastu

AU - Kebriaei, Partow

AU - Garris, Rebecca

AU - Konopleva, Marina

AU - Ravandi, Farhad

AU - Kantarjian, Hagop

PY - 2024/7

Y1 - 2024/7

UR - http://www.scopus.com/inward/record.url?scp=85190561458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85190561458&partnerID=8YFLogxK

U2 - 10.1002/ajh.27329

DO - 10.1002/ajh.27329

M3 - Letter

C2 - 38607091

AN - SCOPUS:85190561458

SN - 0361-8609

VL - 99

SP - 1423

EP - 1426

JO - American journal of hematology

JF - American journal of hematology

IS - 7

ER -

Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this